首页 > 《高分子科学：英文版》 > 2015年7期 > Comparation of Activity against Aβ Aggregation between RR and LPFFD

Comparation of Activity against Aβ Aggregation between RR and LPFFD

在线阅读下载PDF 导出详情

摘要这里，我们介绍RR(RYYAAFFARR)的结构的设计，聚集的一个禁止者用分子的停靠，并且比较在RR和LPFFD之间的禁止的能力，它与主要取决于交往恐水病的相互作用。我们的结果证明能与多重弱相互作用指向A的多重区域的RR比仅仅主要与单个驱动力指向一个单个区域的那些好。

DOI pj09390vjy/1509399

作者 Jing Liu;袁直

机构地区不详

出处《高分子科学：英文版》 2015年7期

关键词聚集弱相互作用结构设计分子对接抑制能力抑制剂

分类 [理学][高分子化学]

出版日期 2015年07月17日（中国期刊网平台首次上网日期，不代表论文的发表时间）

相关文献

1Nie Xu,Liu Huifang,Xu Xinyi,Zhan Yonghua,Xie Hui,Zeng Qi. Antibacterial activity of the ethyl acetate part of Abrus cantoniensis against Staphylococcus aureus.医药卫生,2021-08.
2符永恒;朱杰宁;黄帅;郭林林;林秋雄;张梦珍;谭虹虹;邝素娟;杨惠;费洪文;李文瑜;单志新. MicroRNAs participate in the cardioprotective activity of dexrazoxane against doxorubicin-induced cardiotoxicity.心血管疾病,2012-03.
3Feng Yujun. Strategic Competition between the Major Powers against Changing Global Conditions.国际关系,2013-03.
4王述洋;宋国育. STUDY ON RELATIONS BETWEEN HEAVY-DISASTER-PERIOD OF FOREST FIRE ACTIVITY AND SUNSPOT ACTIVITY, SSTA.林学,1994-04.
5WU Fu-chun. Study on the relationship between geothermal exploitation and seismic activity in Xi.地震学,2001-04.
6Feng Tang;Luting Zhao;Yan Jiang;Denian Ba;Lianxian Cui;Wei He. activity of Recombinant Human Interleukin-15 against Tumor Recurrence and Metastasis in Mice.免疫学,2008-03.
7K. Kumaravel;S. Ravlchandran;F. R. Sharmila Joseph;D. Manikodi;Mauro Doimi. In vitro Antimicrobial Activity of Tissue Extracts of Puffer fish Arothron immaculatus Against Clinical Pathogens.中药学,2011-06.
8王辉;孙宏莉;陈民钧. Molecular Epidemiology of Oxacillin-resistant Staphylococcus aureus and in vitro Activity of Glycopeptides against Staphylococcus species.基础医学,2004-02.
9吴云飞;徐惠绵;陈峻青. INVESTIGATION OF THE RELATIONSHIP BETWEEN CELL PROLIFERATIVE ACTIVITY AND INVASION, METASTASIS AND PROGNOSIS OF GASTRIC CANCER.肿瘤,2004-02.
10祝丽娟;王亚非;尹志聪. RELATIONSHIP BETWEEN TROPICAL ISO AND TROPICAL CYCLONE ACTIVITY OVER THE SOUTH CHINA SEA.大气科学及气象学,2016-03.

来源期刊

高分子科学：英文版

相关推荐

同分类资源更多

相关关键词

聚集弱相互作用结构设计分子对接抑制能力抑制剂

返回顶部